[
  {
    "ts": null,
    "headline": "Here’s What Jim Cramer Wishes Amgen Inc. (AMGN) Should Do To Its Drug That Hurts Like A “Banshee”",
    "summary": "We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer recently discussed. Amgen Inc. (NASDAQ:AMGN) is one of the largest pharmaceutical companies in the world that makes treatments for a variety of ailments such as arthritis, heart problems, and anemia. The shares […]",
    "url": "https://finnhub.io/api/news?id=2deec736a341aecc9cb8c2aeb724b3e7260dfa5fc1641158c027a3f2ba7dc2bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756763971,
      "headline": "Here’s What Jim Cramer Wishes Amgen Inc. (AMGN) Should Do To Its Drug That Hurts Like A “Banshee”",
      "id": 136604267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer recently discussed. Amgen Inc. (NASDAQ:AMGN) is one of the largest pharmaceutical companies in the world that makes treatments for a variety of ailments such as arthritis, heart problems, and anemia. The shares […]",
      "url": "https://finnhub.io/api/news?id=2deec736a341aecc9cb8c2aeb724b3e7260dfa5fc1641158c027a3f2ba7dc2bf"
    }
  },
  {
    "ts": null,
    "headline": "Is Amgen Stock Underperforming the S&P 500?",
    "summary": "Analysts continue to favor Amgen stock, despite its relative underperformance to the broader S&P 500 Index.",
    "url": "https://finnhub.io/api/news?id=54a910e4f3aa52aded4ea4e606dfe1871c9420139d21174b8b7c5351eb226aa7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756742729,
      "headline": "Is Amgen Stock Underperforming the S&P 500?",
      "id": 136604268,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Analysts continue to favor Amgen stock, despite its relative underperformance to the broader S&P 500 Index.",
      "url": "https://finnhub.io/api/news?id=54a910e4f3aa52aded4ea4e606dfe1871c9420139d21174b8b7c5351eb226aa7"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Amgen (AMGN) is a Strong Value Stock",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=9d54ca14171456bfb21c8b9dba9a374ea72cd3ba9b8cb50816c02ae22cb7488b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756737601,
      "headline": "Here's Why Amgen (AMGN) is a Strong Value Stock",
      "id": 136604269,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=9d54ca14171456bfb21c8b9dba9a374ea72cd3ba9b8cb50816c02ae22cb7488b"
    }
  },
  {
    "ts": null,
    "headline": "BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH",
    "summary": "Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated.",
    "url": "https://finnhub.io/api/news?id=e65c08ad2a06131c5a323482f6577e24c9425ef649ed73a4e4c31fd02b107a38",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756713836,
      "headline": "BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH",
      "id": 136595546,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2199321843/image_2199321843.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated.",
      "url": "https://finnhub.io/api/news?id=e65c08ad2a06131c5a323482f6577e24c9425ef649ed73a4e4c31fd02b107a38"
    }
  },
  {
    "ts": null,
    "headline": "2 Profitable Stocks Worth Your Attention and 1 We Avoid",
    "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, \"Your margin is my opportunity\".",
    "url": "https://finnhub.io/api/news?id=f672a24408387d32443400b79cdb7aa4b82f35a38091326c6bbd3c7122516a8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756704696,
      "headline": "2 Profitable Stocks Worth Your Attention and 1 We Avoid",
      "id": 136596282,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, \"Your margin is my opportunity\".",
      "url": "https://finnhub.io/api/news?id=f672a24408387d32443400b79cdb7aa4b82f35a38091326c6bbd3c7122516a8c"
    }
  }
]